PTC Therapeutics, Inc.: PTC Therapeutics Announces European

- European Commission decides against adoption of negative opinion -- Translarna authorization remains active in Europe -- 2024 revenue guidance paused - WARREN, N.J., May 20, 2024 /PRNewswire/

Related Keywords

Brazil , United States , Russia , Jeanine Clemente , Kylie Okeefe , Matthewb Klein , Scientific Advisory Group , European Medicines Agency , Therapeutics Inc , Committee For Medicinal Products Human , Nasdaq , European Commission , Committee For Medicinal Products Human Use , Chief Executive Officer , Duchenne Muscular Dystrophy , More Information , Private Securities Litigation Reform Act , Medicinal Products , Human Use , European Economic Area , Quarterly Report , Annual Report , Ihr Portfolio ,